Aias-Theodoros Papastavrou, MD, PhD – Medium

Aias-Theodoros Papastavrou, MD, PhD

COVID-19: CBD right from the start? Newer research data

Summary: CBD has been shown to down-regulate ACE2Rs and TMPRSS2Rs, both of which facilitate the inoculation of SARS-CoV-2. CBD has also…

Nov 18, 2021

Nov 18, 2021

Glioblastoma and cannabis: Mechanisms of beneficial and adverse effects

Cannabis is a promising addition to GBM treatment; a lot of subtleties that need medical attention. Apoptosis vs. Autophagy

Oct 16, 2020

Glioblastoma and cannabis: Mechanisms of beneficial and adverse effects

Oct 16, 2020

COVID-19 pandemic:

Measures to be taken for its prevention and treatment

Jun 8, 2020

COVID-19 pandemic:

Jun 8, 2020

Are men and women equal before Cannabis?

It turns out that they are equal but different. Why is that?

May 11, 2020

May 11, 2020

DEMENTIA & CANNABIS

Can we do better?

Apr 26, 2020

Caring for the demented

Apr 26, 2020

Melatonin & Acetaminophen use in COVID19 cases

A neglected multi-purpose hormone and a simple analgesic in action

Apr 23, 2020

Melatonin & Acetaminophen use in COVID19 cases

Apr 23, 2020

The quest for a healthy Endo-Cannabinoid System (ECS)

Emphasis on immunoregulation: The ECS is a disease modifier

Apr 22, 2020

The quest for a healthy Endo-Cannabinoid System (ECS)

Apr 22, 2020

COVID19 & CANNABIS

Is it ethical not to investigate the use of phytocannabinoids?

Apr 17, 2020

This scanning electron microscope image shows SARS-CoV-2, the virus that causes COVID-19 — isolated from a patient.

Apr 17, 2020

Aias-Theodoros Papastavrou, MD, PhD

Aias-Theodoros Papastavrou, MD, PhD

Medical director at Biomed Aid Ltd. Integrative Medicine (Medicinal Cannabis, Epigenetics, Nutrition, Hyperthermia). https://bit.ly/3CnYxK8

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams